ATE167518T1 - Zellzyklusprotein in säugetieren - Google Patents

Zellzyklusprotein in säugetieren

Info

Publication number
ATE167518T1
ATE167518T1 AT95910987T AT95910987T ATE167518T1 AT E167518 T1 ATE167518 T1 AT E167518T1 AT 95910987 T AT95910987 T AT 95910987T AT 95910987 T AT95910987 T AT 95910987T AT E167518 T1 ATE167518 T1 AT E167518T1
Authority
AT
Austria
Prior art keywords
p55cdc
cell cycle
mammals
cycle protein
protein
Prior art date
Application number
AT95910987T
Other languages
English (en)
Inventor
Jasminder Weinstein
Original Assignee
Amgen Inc
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc, Univ California filed Critical Amgen Inc
Application granted granted Critical
Publication of ATE167518T1 publication Critical patent/ATE167518T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT95910987T 1994-02-14 1995-02-13 Zellzyklusprotein in säugetieren ATE167518T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19573094A 1994-02-14 1994-02-14

Publications (1)

Publication Number Publication Date
ATE167518T1 true ATE167518T1 (de) 1998-07-15

Family

ID=22722553

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95910987T ATE167518T1 (de) 1994-02-14 1995-02-13 Zellzyklusprotein in säugetieren

Country Status (12)

Country Link
US (2) US6291642B1 (de)
EP (1) EP0745124B1 (de)
JP (1) JP3064012B2 (de)
AT (1) ATE167518T1 (de)
AU (1) AU700350B2 (de)
CA (1) CA2183254A1 (de)
DE (1) DE69503038T2 (de)
DK (1) DK0745124T3 (de)
ES (1) ES2117855T3 (de)
GR (1) GR3027621T3 (de)
IL (1) IL112642A (de)
WO (1) WO1995021917A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69503038T2 (de) * 1994-02-14 1999-03-25 Amgen Inc., Thousand Oaks, Calif. Zellzyklusprotein in Säugetieren
US5851821A (en) * 1996-05-02 1998-12-22 Cold Spring Harbor Laboratory DNA Replication-regulating genes
US6361954B1 (en) 1996-05-02 2002-03-26 Cold Spring Harbor Laboratory Methods of immunoassay for human CDC6
US6074819A (en) * 1996-05-02 2000-06-13 Cold Spring Harbor Laboratory DNA replication-regulating genes
FR2779433B1 (fr) * 1998-06-08 2002-08-16 Centre Nat Rech Scient Proteine vegetale a motifs wd40 repetes, acide nucleique codant pour ladite proteine, et leurs applications
WO2006006948A2 (en) 2002-11-14 2006-01-19 Dharmacon, Inc. METHODS AND COMPOSITIONS FOR SELECTING siRNA OF IMPROVED FUNCTIONALITY
US7951935B2 (en) 2002-11-14 2011-05-31 Dharmacon, Inc. siRNA targeting v-myc myelocytomatosis viral oncogene homolog (MYC)
US7619081B2 (en) * 2002-11-14 2009-11-17 Dharmacon, Inc. siRNA targeting coatomer protein complex, subunit beta 2 (COPB2)
US8198427B1 (en) 2002-11-14 2012-06-12 Dharmacon, Inc. SiRNA targeting catenin, beta-1 (CTNNB1)
US7977471B2 (en) * 2002-11-14 2011-07-12 Dharmacon, Inc. siRNA targeting TNFα
US7592442B2 (en) * 2002-11-14 2009-09-22 Dharmacon, Inc. siRNA targeting ribonucleotide reductase M2 polypeptide (RRM2 or RNR-R2)
US9771586B2 (en) 2002-11-14 2017-09-26 Thermo Fisher Scientific Inc. RNAi targeting ZNF205
US9839649B2 (en) 2002-11-14 2017-12-12 Thermo Fisher Scientific Inc. Methods and compositions for selecting siRNA of improved functionality
US20080268457A1 (en) * 2002-11-14 2008-10-30 Dharmacon, Inc. siRNA targeting forkhead box P3 (FOXP3)
US7612196B2 (en) * 2002-11-14 2009-11-03 Dharmacon, Inc. siRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)
US9228186B2 (en) 2002-11-14 2016-01-05 Thermo Fisher Scientific Inc. Methods and compositions for selecting siRNA of improved functionality
US7781575B2 (en) 2002-11-14 2010-08-24 Dharmacon, Inc. siRNA targeting tumor protein 53 (p53)
US7691998B2 (en) * 2002-11-14 2010-04-06 Dharmacon, Inc. siRNA targeting nucleoporin 62kDa (Nup62)
US9719092B2 (en) 2002-11-14 2017-08-01 Thermo Fisher Scientific Inc. RNAi targeting CNTD2
AU2003295600A1 (en) * 2002-11-14 2004-06-15 Dharmacon, Inc. Functional and hyperfunctional sirna
US7635770B2 (en) * 2002-11-14 2009-12-22 Dharmacon, Inc. siRNA targeting protein kinase N-3 (PKN-3)
US9719094B2 (en) 2002-11-14 2017-08-01 Thermo Fisher Scientific Inc. RNAi targeting SEC61G
US20090227780A1 (en) * 2002-11-14 2009-09-10 Dharmacon, Inc. siRNA targeting connexin 43
US9879266B2 (en) 2002-11-14 2018-01-30 Thermo Fisher Scientific Inc. Methods and compositions for selecting siRNA of improved functionality
US20100113307A1 (en) * 2002-11-14 2010-05-06 Dharmacon, Inc. siRNA targeting vascular endothelial growth factor (VEGF)
US10011836B2 (en) 2002-11-14 2018-07-03 Thermo Fisher Scientific Inc. Methods and compositions for selecting siRNA of improved functionality
US7605250B2 (en) * 2004-05-12 2009-10-20 Dharmacon, Inc. siRNA targeting cAMP-specific phosphodiesterase 4D
JP4131271B2 (ja) * 2005-03-30 2008-08-13 ソニー株式会社 情報処理装置および方法、並びにプログラム
US9799416B2 (en) * 2009-11-06 2017-10-24 Terrapower, Llc Methods and systems for migrating fuel assemblies in a nuclear fission reactor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
US4879213A (en) 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
DE69503038T2 (de) * 1994-02-14 1999-03-25 Amgen Inc., Thousand Oaks, Calif. Zellzyklusprotein in Säugetieren

Also Published As

Publication number Publication date
DK0745124T3 (da) 1999-02-01
US6291642B1 (en) 2001-09-18
GR3027621T3 (en) 1998-11-30
JPH09504959A (ja) 1997-05-20
EP0745124B1 (de) 1998-06-17
CA2183254A1 (en) 1995-08-17
DE69503038T2 (de) 1999-03-25
DE69503038D1 (de) 1998-07-23
AU1875695A (en) 1995-08-29
US20020035240A1 (en) 2002-03-21
JP3064012B2 (ja) 2000-07-12
IL112642A (en) 2001-11-25
ES2117855T3 (es) 1998-08-16
EP0745124A1 (de) 1996-12-04
US6673903B2 (en) 2004-01-06
AU700350B2 (en) 1999-01-07
WO1995021917A1 (en) 1995-08-17
IL112642A0 (en) 1995-05-26

Similar Documents

Publication Publication Date Title
ATE167518T1 (de) Zellzyklusprotein in säugetieren
DK0526452T3 (da) Hybridimmunoglobuliner
DK1482040T3 (da) NL3-TIE-receptortyrosinkinaseligandhomologer
DE59608743D1 (de) Verfahren zur herstellung von rekombinanten proteinen in e. coli mittels hochzelldichte-fermentation
DE3583194D1 (de) Verfahren zur herstellung von einem polypeptid mittels eines transformierten mikroorganismus, ein dazu geeigneter transformierter mikroorganismus, und zur herstellung dieser mikroorganismen geeignete dns sequenzen.
ATE449175T1 (de) Bakterielle produktion von interferon-beta polypeptiden
DE3688061D1 (de) Verfahren zur herstellung von tonern mittels suspensionspolymerisation.
DE3682928D1 (de) Verfahren zum polymerisieren von aethylen.
DK0981630T3 (da) Polypeptider med prolyldipeptidylaminopeptidaseaktivitet og nukleinsyrer, der koder for samme
DE3786279D1 (de) Verfahren zur selektivbestimmung von mikrobiellen nukleotiden.
NO853012L (no) Nye genetiske sekvenser, interfenonpeptider av type i uttrykt av disse og organismer som produserer dem.
DE69535696D1 (de) Tripeptidyl-aminopeptidase
NO176807C (no) Sammensmeltet gen som koder for et hybridprotein, samt fremgangsmåte for fremstilling av et hybridprotein som kodes av et sammensmeltet gen; vektor og sammensmeltet gen
DE69837475D1 (de) Polypeptide mit aminopeptidaseaktivität und dafür kodierende nukleinsäuren
DE59103472D1 (de) Chromsäure-Herstellung unter Verwendung von bipolaren Membranen.
DE3576361D1 (de) Rekombinante dna, damit transformierter mikroorganismus, und verfahren zur herstellung von menschlicher cu-zn superoxiddismutase unter verwendung des transformierten mikroorganismus.
DE58902137D1 (de) Verfahren zur herstellung von caprolacton.
ATE315644T1 (de) Für das igg-fc-bindende protein kodierendes gen
ATE102994T1 (de) Verfahren zur herstellung von proteinen.
DE69013483D1 (de) Membransystem und Verfahren zum Konzentrieren von organischen Sauerstoffverbindungen.
DE3685337D1 (de) Verfahren zur herstellung von amiden unter verwendung von mikroorganismen.
FI844213A7 (fi) Menetelmä DNA:n tai DNA-fragmentin emässekvenssin määrittämiseksi käyttäen autoradiografiaa.
DE3581958D1 (de) Verfahren zur herstellung von n-acetylneuraminat-lyase.
DE3582368D1 (de) Verfahren zur herstellung von epoxyden mittels mikroorganismen.
DE3767659D1 (de) Verfahren und testelement zum auffinden von zellaesionen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee